Johnson & Johnson JNJ
NYSE JNJ
$270.24 +2.87 (+1.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Income towards Parent Company (2009 - 2026)

Johnson & Johnson (JNJ) posted Income towards Parent Company of $5.5 billion for Q2 2026, up 5.71% sequentially from $5.2 billion in Q1 2026, and little changed YoY from $5.5 billion in Q2 2025.

Johnson & Johnson (JNJ) Income towards Parent Company (2009 - 2026) Analysis & Trends

Johnson & Johnson has reported Income towards Parent Company for 17 years, with the latest figure at $5.5 billion in Q2 2026.

  • Quarterly Income towards Parent Company changed 0.05% year-over-year to $5.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $21.0 billion (up 27.22% YoY) and the FY2023 annual result came in at $21.8 billion, up 1289.37% from the prior year.
  • Income towards Parent Company advanced to $5.5 billion in Q2 2026 per JNJ's latest filing, from $5.2 billion in the prior quarter.
  • Over five years, Income towards Parent Company peaked at $21.7 billion in Q4 2023 and troughed at -$232.0 million in Q3 2023.
  • A 4-year average of $4.4 billion and a median of $2.8 billion in 2022 frame the typical range for Income towards Parent Company.
  • The widest YoY moves for Income towards Parent Company: up 14575.0% in 2023, down 142.03% in 2023.
  • Over 4 years, Income towards Parent Company stood at $148.0 million in 2022, then plunged by 156.08% to -$83.0 million in 2023, then soared by 6263.86% to $5.1 billion in 2025, then gained by 8.17% to $5.5 billion in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered $5.5 billion, $5.2 billion, and $5.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn

Historic Data

Download Data
DateValue
Jun 28, 2026 5.53 Bn
Mar 29, 2026 5.24 Bn
Dec 28, 2025 5.12 Bn
Sep 28, 2025 5.15 Bn
Jun 29, 2025 5.54 Bn
Mar 30, 2025 11.00 Bn
Dec 31, 2023 -83.00 Mn
Oct 1, 2023 21.72 Bn
Jul 2, 2023 -232.00 Mn
Apr 2, 2023 423.00 Mn
Jan 1, 2023 293.00 Mn
Oct 2, 2022 148.00 Mn
Jul 3, 2022 552.00 Mn
Apr 3, 2022 578.00 Mn
Oct 3, 2021 3.67 Bn
Jul 4, 2021 6.28 Bn
Apr 4, 2021 6.20 Bn
Jan 3, 2021 1.74 Bn
Sep 27, 2020 3.55 Bn
Jun 28, 2020 3.63 Bn